International Clinical Trial: A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of oral PRX-101 in healthy participants (Part 1)

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000894493) titled 'A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of oral PRX-101 in healthy participants (Part 1)' on Aug. 18.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Open (masking not used) Assignment: Crossover

Primary Sponsor: Phocus Pharmaceuticals, Inc.

Condition: paroxysmal supraventricular tachycardia paroxysmal supraventricular tachycardia Cardiovascular - Other cardiovascular diseases

Intervention: Twenty participants will be randomized to one of four drug sequences with 3 different oral doses of PRX-101 and...